TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Biotage Sweden AB
Closing information (x1000 SEK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
719,251
|
872,384
|
766,964 |
| Financial expenses |
1
|
30,027
|
6,514 |
| Earnings before taxes |
186,817
|
235,811
|
187,474 |
| EBITDA |
180,327
|
268,576
|
197,872 |
| Total assets |
672,567
|
580,083
|
544,416 |
| Current assets |
662,395
|
568,564
|
530,104 |
| Current liabilities |
257,536
|
266,381
|
210,832 |
| Equity capital |
406,254
|
305,788
|
317,255 |
| - share capital |
3,867
|
3,867
|
3,867 |
| Employees (average) |
92
|
93
|
95 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
60.4%
|
52.7%
|
58.3% |
| Turnover per employee |
7,818
|
9,380
|
8,073 |
| Profit as a percentage of turnover |
26.0%
|
27.0%
|
24.4% |
| Return on assets (ROA) |
27.8%
|
45.8%
|
35.6% |
| Current ratio |
257.2%
|
213.4%
|
251.4% |
| Return on equity (ROE) |
46.0%
|
77.1%
|
59.1% |
| Change turnover |
-153,133
|
105,420
|
51,509 |
| Change turnover % |
-18%
|
14%
|
7% |
| Chg. No. of employees |
-1
|
-2
|
-2 |
| Chg. No. of employees % |
-1%
|
-2%
|
-2% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.